Literature DB >> 23523373

Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience.

Karen D Ersche1, Guy B Williams, Trevor W Robbins, Edward T Bullmore.   

Abstract

Since the first study in stimulant-dependent individuals using structural MRI was published fifteen years ago, much evidence has accumulated on brain abnormalities associated with stimulant drug dependence. Here we conducted a voxel-based morphometry meta-analysis of published MRI data in stimulant-dependent individuals to clarify the most robust abnormalities underlying the disorder. We found that neuroimaging studies in stimulant-dependent individuals consistently report a gray matter decline in the prefrontal cortex regions associated with self-regulation and self-awareness. One of the next key questions that neuroimaging research today needs to address is the question of causality, namely to what extent these brain abnormalities are caused by the toxic effects of drug exposure, or the possibility that these may have predated drug-taking and even predisposed individuals for the development of drug dependence. Although the question of causality has not yet been answered completely, there has been significant progress made to date.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23523373     DOI: 10.1016/j.conb.2013.02.017

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  72 in total

1.  Altered white matter connectivity in young people exposed to childhood abuse: a tract-based spatial statistics (TBSS) and tractography study

Authors:  Lena Lim; Heledd Hart; Henrietta Howells; Mitul A. Mehta; Andrew Simmons; Kah Mirza; Katya Rubia
Journal:  J Psychiatry Neurosci       Date:  2019-07-01       Impact factor: 6.186

2.  Implications of the Hierarchical Structure of Psychopathology for Psychiatric Neuroimaging.

Authors:  David H Zald; Benjamin B Lahey
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-05

Review 3.  Neuroimaging reward, craving, learning, and cognitive control in substance use disorders: review and implications for treatment.

Authors:  Jody Tanabe; Michael Regner; Joseph Sakai; Diana Martinez; Joshua Gowin
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

Review 4.  Fractionating impulsivity: neuropsychiatric implications.

Authors:  Jeffrey W Dalley; Trevor W Robbins
Journal:  Nat Rev Neurosci       Date:  2017-02-17       Impact factor: 34.870

5.  Examining neural correlates of psychopathology using a lesion-based approach.

Authors:  Matthew Calamia; Kristian E Markon; Matthew J Sutterer; Daniel Tranel
Journal:  Neuropsychologia       Date:  2018-06-27       Impact factor: 3.139

6.  Altered regional brain volumes in elderly carriers of a risk variant for drug abuse in the dopamine D2 receptor gene (DRD2).

Authors:  Florence F Roussotte; Neda Jahanshad; Derrek P Hibar; Paul M Thompson
Journal:  Brain Imaging Behav       Date:  2015-06       Impact factor: 3.978

Review 7.  Contributions of the insula to cognition and emotion.

Authors:  Philip Gerard Gasquoine
Journal:  Neuropsychol Rev       Date:  2014-01-18       Impact factor: 7.444

8.  Evaluation of structural connectivity changes in betel-quid chewers using generalized q-sampling MRI.

Authors:  Jun-Cheng Weng; Te-Wei Kao; Guo-Joe Huang; Yeu-Sheng Tyan; Hsien-Chun Tseng; Ming-Chou Ho
Journal:  Psychopharmacology (Berl)       Date:  2017-03-24       Impact factor: 4.530

9.  Harm reduction: compassionate care of persons with addictions.

Authors:  Robin Bartlett; Laura Brown; Mona Shattell; Thelma Wright; Lynne Lewallen
Journal:  Medsurg Nurs       Date:  2013 Nov-Dec

10.  Cerebral gray matter volumes and low-frequency fluctuation of BOLD signals in cocaine dependence: duration of use and gender difference.

Authors:  Jaime S Ide; Sheng Zhang; Sien Hu; Rajita Sinha; Carolyn M Mazure; Chiang-Shan R Li
Journal:  Drug Alcohol Depend       Date:  2013-09-17       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.